# Performance and Tolerability of a New Medical Device Gel, a Randomized, Open Label, Parallel-group, Multicentre Study

> **NCT03423784** · NA · COMPLETED · sponsor: **Opera CRO, a TIGERMED Group Company** · enrollment: 54 (actual)

## Conditions studied

- Tooth Disease

## Interventions

- **DEVICE:** HA BPX V3.3
- **OTHER:** Dentinox-Gel N

## Key facts

- **NCT ID:** NCT03423784
- **Lead sponsor:** Opera CRO, a TIGERMED Group Company
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-15
- **Primary completion:** 2015-03-31
- **Final completion:** 2015-06-30
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423784, "Performance and Tolerability of a New Medical Device Gel, a Randomized, Open Label, Parallel-group, Multicentre Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03423784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*